Study Details

Study Identifiers

Study title

PFAS in Dutch population

Short name or acronym

Secondary identifiers

Description/Abstract

A recent study by the Dutch RIVM found that across The Netherlands seven PFAS are found in every tested human, with an additional nine found in at least 10% of the population.

Keywords

PFAS

Activity status

Principle Investigators

Principal investigator

Name

Affiliation

Address line 1

Address line 2

Address line 3

County

Country

PostCode

Email

ORCID Id

Telephone number

Type of organisation

Sector

Secondary investigator

Name

Affiliation

Address line 1

Address line 2

Address line 3

County

Country

PostCode

Email

ORCID Id

Telephone number

Type of organisation

Sector

Contact Persons

Contact person

Name

Affiliation

Address line 1

Address line 2

Address line 3

County

Country

PostCode

Email

ORCID Id

Telephone number

Type of organisation

Sector

Scientific contact person

Name

Affiliation

Address line 1

Address line 2

Address line 3

County

Country

PostCode

Email

ORCID Id

Telephone number

Type of organisation

Sector

Study Metadata

Coverage level

National

Main country

Netherlands

Collaborating countries

Main language of study

Collaborating organisations

Type of study

General Population Research Study

Ethical Approval

Has the study recieved ethical approval

If no, why not?

If yes, please provide the name of the approving body

Reference number of ethical approval (if available)

What incentives/compensation is provided for study applicants

Are informed consents obtained?

Population Metadata

Methods of questionnaire administration

Is questionnaire avaiable online, if yes please provide a link

Will Date of Birth/Age at the time of study enrollment be collected

Is Biological sex (at birth) of participants considered in study population defined as following? (Male, Female, intersex)

Is the current gender of participants considered in study population as follows?

Is the infromation on different aspects of socio demographic be collected? Please tick the relevant boxes

What type of anthropometric measurements are performed by fieldworkers? (mulitple answers are possible)

What Lifestyle information is available for each participant?

What food and drinks information is available for each participant?

What environmental factors information is collected?

What historical data will be collected?

Exposure information

For occupational, shift patterns would be important to know? 8h/d,5d/wk or 12h/d,3d/wk or day/back/night etc.

Which job roles or tasks involve the highest likelihood of exposure to chemical mixtures?

How do work practices, such as handling, storage, or disposal of chemicals, contribute to the formation or dispersion of mixtures in the workplace?

Describe the actual tasks that workers perform at the company's site

What are the primary sources of exposure being investigated?

Processes and techniques

Type of processes

Exposure routes

Worker behaviour (experiance of the workforce)

Particular tasks or conditions during measurement

Sample Collection

Biological matrix collected

When Blood collected which part of Blood will be used for analysis

Workplace monitoring

If Dermal sampling, Please specify the method used

Envrionmental monitoring

Start date of sample collection

End date of sample collection

Frequency of sample collection

0

Time of sample collection

Is sample collection seasonal, if yes what seasons are included

Time of exposure (for occupational biomonitoring)

Indicate how many cycles

0

Sample collection cycle, Date from

Sample collection cycle, Date to

Number of samples

0

Individual Workers

0

Similar Exposure Groups (SEGs)

How SEGs are determind?

Sampling collection time points with respect to anticipated exposure time (e.g., spot urines amples collected post-shift or 24 h urine collection)

The sampling collection interval (e. g. spot urine samples after every work shift over 3 weeks,aligned with elimination half-life time of the investigated analytes)

The number of samples per worker

0

The number of samples for group-based measurements

0

Where does sample collection take place

Who will draw blood samples

Prior sample collection condition(s)

SOP for msample storage and transport

Were samples processed and aliqouted

Is a limit from the point of collection set for blood samples to be prosessed and stored, if yes please indicate e.g. 4 hours

Time interval for shipment of samples to targeted Laboratory, e.g. Once a week

Shipment conditions

Storage condition before analysis

Dilution level

Blood lipids

Does the biomarker of exposure accurately reflect the intended use?

Exposure data modelling will be applied?, if yes details

GIS (other spatial methods) will be applied?, if yes details

Expert assessment of exposure will be applied?, if yes details

Participant self report of exposure?, if yes details

Sensors used

Data Analysis Plan

Is the analysis being undertaken by trained statisticians

Data transformations or scaling applied

How is the raw data processed and analyzed?

If software-based, which software is utilized?

What statistical methods will be used for data analysis?

Is there a plan for data harmonization if multiple studies are involved?

Outline data cleaning procdures

Handling values below LOD

Handling values below LOQ

Are they 'blind' to the study (not involved in field work)?

Descriptive analysis

Stratification procedures

Are uncertainties or confidence intervals provided with the results?

Are the analytical methods or results externally validated or peer-reviewed? If yes, by whom or through which process

Do you have any pre-existing health conditions that may affect the interpretation of biomonitoring data?

Unit of measurment

Value as measured, i.e. prior to any correction for worn PPE or duration

Analytical error for a single measurement

Number of samples below LOQ

0

Variance estimation

Modelling to be taken

Sensitivity analysis

Biobanking

Will the collected biomonitoring samples be biobanked for potential further analysis?

Which samples will be biobanked?

How long will they be biobanked for? (years)

0

What approvals have been granted by ethics committee regarding further analysis of the samples?

Are they available to third parties on request?

If yes, provide contact details of who to approach concerning this (name, email, telephone number)

Reporting Dissemination

Will study results be communicated to the following stakeholders?

For each of the indicated groups, how will the study findings be communicated?

For each of the indicated groups, how often will the study findings be communicated?

What type of data registeries will be linked?

Is data linked to relevant publications?

Would you like the system to conduct risk assessment?

Reporting at workplace

Reporting forgeneral population (publication)

Study Identifiers

Principle Investigators

Contact Persons

Study Metadata

Ethical Approval

Study Design

Target Group

Data Management

Chemicals

perfluorohexanesulfonic acid

perfluorodecanoic acid

perfluorooctanoic acid

perfluorononanoic acid

perfluorooctane-1-sulfonic acid

perfluoroundecanoic acid

Population Metadata

Sample Collection

Data Analysis Plan

Analytical EB Targted

Biobanking

Reporting Dissemination